Ignite Creation Date:
2024-05-06 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03602300
Status:
COMPLETED
Last Update Posted:
2020-01-31
First Post:
2018-06-21
Brief Title:
A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study
Sponsor:
Drugs for Neglected Diseases
Organization:
Drugs for Neglected Diseases
Organization Data
Organization:
Drugs for Neglected Diseases
Class:
OTHER
Study ID:
DNDi-RDV-02-HCV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Drugs for Neglected Diseases
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None